Spannuth WA - Search Results

1

A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer.

Moore KN, Herzog TJ, Lewin S, Giuntoli RL, Armstrong DK, Rocconi RP, Spannuth WA, Gold MA. Moore KN, et al. Among authors: spannuth wa. Gynecol Oncol. 2007 May;105(2):299-303. doi: 10.1016/j.ygyno.2006.12.031. Epub 2007 Feb 14. Gynecol Oncol. 2007. PMID: 17303230

2

Gamma mode of infiltration associated with poor prognosis in malignant teratoma of the ovary: A case report.

Spannuth WA, Rocconi RP, Kirby TO, Huh WK, Conner MG. Spannuth WA, et al. Gynecol Oncol. 2005 Jul;98(1):155-7. doi: 10.1016/j.ygyno.2005.04.011. Gynecol Oncol. 2005. PMID: 15922442

3

A comparison of hand-assisted laparoscopy and conventional laparotomy for the surgical evaluation of pelvic masses.

Spannuth WA, Rocconi RP, Huh WK, Straughn JM Jr, Barnes MN 3rd. Spannuth WA, et al. Gynecol Oncol. 2005 Nov;99(2):443-6. doi: 10.1016/j.ygyno.2005.06.049. Epub 2005 Aug 31. Gynecol Oncol. 2005. PMID: 16137745

4

A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapy.

Spannuth WA, Leath CA 3rd, Huh WK, Barnes MN 3rd, Davidson SA, Kilgore LC, Partridge EE, Austin JM 2nd, Alvarez RD. Spannuth WA, et al. Gynecol Oncol. 2007 Mar;104(3):591-5. doi: 10.1016/j.ygyno.2006.09.008. Epub 2006 Oct 12. Gynecol Oncol. 2007. PMID: 17045635 Clinical Trial.

5

Feasibility of extension of platinum-free interval with weekly bolus topotecan and subsequent platinum retreatment outcomes in recurrent ovarian cancer.

Bryant CS, Kumar S, Spannuth W, Shah JP, Munkarah AR, Deppe G, Alvarez RD, Morris RT. Bryant CS, et al. Arch Gynecol Obstet. 2011 Feb;283(2):361-7. doi: 10.1007/s00404-010-1462-9. Epub 2010 Apr 11. Arch Gynecol Obstet. 2011. PMID: 20383771

6

Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists.

Soliman PT, Frumovitz M, Spannuth W, Greer MJ, Sharma S, Schmeler KM, Ramirez PT, Levenback CF, Ramondetta LM. Soliman PT, et al. Gynecol Oncol. 2010 Nov;119(2):291-4. doi: 10.1016/j.ygyno.2010.07.011. Epub 2010 Aug 12. Gynecol Oncol. 2010. PMID: 20708226 Free PMC article.

7

Inflammatory pseudotumor of pelvic lymph nodes.

Spannuth WA, Leath CA 3rd, Conner MG, Alvarez RD. Spannuth WA, et al. Obstet Gynecol. 2006 Sep;108(3 Pt 2):779-82. doi: 10.1097/01.AOG.0000201973.13715.ee. Obstet Gynecol. 2006. PMID: 17018500

8

Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients.

Landen CN Jr, Lin YG, Immaneni A, Deavers MT, Merritt WM, Spannuth WA, Bodurka DC, Gershenson DM, Brinkley WR, Sood AK. Landen CN Jr, et al. Among authors: spannuth wa. Clin Cancer Res. 2007 Jul 15;13(14):4098-104. doi: 10.1158/1078-0432.CCR-07-0431. Clin Cancer Res. 2007. PMID: 17634535

9

Farletuzumab in epithelial ovarian carcinoma.

Spannuth WA, Sood AK, Coleman RL. Spannuth WA, et al. Expert Opin Biol Ther. 2010 Mar;10(3):431-7. doi: 10.1517/14712591003592069. Expert Opin Biol Ther. 2010. PMID: 20092424 Review.

10

Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma.

Merritt WM, Danes CG, Shahzad MM, Lin YG, Kamat AA, Han LY, Spannuth WA, Nick AM, Mangala LS, Stone RL, Kim HS, Gershenson DM, Jaffe RB, Coleman RL, Chandra J, Sood AK. Merritt WM, et al. Among authors: spannuth wa. Cancer Biol Ther. 2009 Aug;8(16):1596-603. doi: 10.4161/cbt.8.16.9004. Epub 2009 Aug 13. Cancer Biol Ther. 2009. PMID: 19738426 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters